Page 2 - பெர்கோஃபர் மருத்துவ ஆராய்ச்சி நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CSIRO CSIRO, Australia’s national science agency, will spearhead a $1.7 million project to identify new treatments for COVID-19, including ‘long-COVID’. Scientists will develop a faster, smarter way of rapidly screening existing drugs and advancing those that can be used to treat COVID-19 and aim to have identified thee suitable TGA- or FDA-approved drug candidates to progress to phase 2-3 human clinical trials within a year. Led by researchers at CSIRO’s Australian Centre for Disease Preparedness in Geelong, the project received $1 million in funding from the Australian Government’s Medical Research Future Fund (MRFF), with the remaining contributed by CSIRO.

South australiaDeakin universityMonash universitySwinburne university of technologyAustralian government medical research future fundGeelong centre for emerging infectious diseasesBerghofer medical research instituteStem cell therapies missionUniversity of new south walesUniversity of melbourneDangerous pathogens team leaderAustralian centre for disease preparedness in geelongBarwon healthDisease preparednessAustralian governmentMedical research future fund